| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8662526 | International Journal of Cardiology | 2018 | 5 Pages |
Abstract
The qualities of inclusion criteria are heterogeneous and significantly improved with time in registered HFpEF clinical trials. EF, symptoms and signs should be specified at trial registration to make a more reliable diagnosis and to recruit a more homogenous population.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hongxing Luo, Yu Xu, Fengyang Yue, Cong Zhang, Chang Chen,